NCT04347629Completed
Improving Medical Decision Making for Older Patients With End Stage Renal Disease
Source: ClinicalTrials.gov · Last updated 26 Oct 2026
Brief summary (registry, in English)
The overall objective of this study is to reduce the burden of chronic kidney disease (CKD) and its consequences for an aging U.S. population. To accomplish this, the investigators propose to conduct a multi-center randomized trial of an advance care planning (ACP) video intervention (vs. usual care) among older patients with CKD.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 456 (actual)
- First submitted
- 11 Apr 2020
- Start date
- 21 Jun 2021
- Primary completion date
- 31 Mar 2026
- Lead sponsor
- Tufts Medical Center
- Diseases
- Chronic kidney disease
- NCT number
- NCT04347629
What you commit to
- Study type: Interventional
- Participants enrolled: 456
- From 21 Jun 2021 to the primary completion date, 31 Mar 2026
- 9 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- listed for kidney transplantation or previous transplant recipient
- already on or previously on dialysis (including emergent dialysis)
Other illness
- cognitive impairment
Other
- new patient visit
- visually impaired beyond 20/200 corrected
- psychological state not appropriate for ACP discussions as determined by the primary nephrologist
Who the study is looking for
- Patients age ≥70 are eligible if they have EITHER Advanced CKD defined as ONE eGFR value ≤ 30 ml/min/1.73m2 in the past 12 months NOT determined to be a result of AKI OR Have a diagnosis of CKD and less than a two-year prognosis from any cause, defined by the clinician answering "NO" to the Surprise Question ("Would you be surprised if this patients died in the next two years?")
- Patients age 65-69 are eligible if they have BOTH Advanced CKD defined as ONE eGFR value ≤ 30 ml/min/1.73m2 NOT determined to be a result of AKI AND Have less than a two-year prognosis, defined by the clinician answering "NO" to the Surprise Question ("Would you be surprised if this patients died in the next two years?")
- Patients who have not had a nephrology visit in the past 12 months can be recruited from non-Nephrology Clinics per the above eligibility criteria
Age in the registry: 65 years to - · Sex: All · Does not accept healthy volunteers
Sites (9)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The University of New Mexico Health Sciences Center Coordinator of this site? Confirm its status | Albuquerque | United States | Unknown status |
| Boston Medical Center Coordinator of this site? Confirm its status | Boston | United States | Unknown status |
| Massachusetts General Hospital Coordinator of this site? Confirm its status | Boston | United States | Unknown status |
| Brigham & Women's Hospital Coordinator of this site? Confirm its status | Boston | United States | Unknown status |
| VA Palo Alto Health Care System Coordinator of this site? Confirm its status | Palo Alto | United States | Unknown status |
| Stanford University Coordinator of this site? Confirm its status | Palo Alto | United States | Unknown status |
| University of Pennsylvania Coordinator of this site? Confirm its status | Philadelphia | United States | Unknown status |
| University of Washington Coordinator of this site? Confirm its status | Seattle | United States | Unknown status |
| Renal and Transplant Associates of New England, PC Coordinator of this site? Confirm its status | Springfield | United States | Unknown status |
Related publications
- Video Decision Support and Advance Care Planning in Older Adults With Advanced Kidney Disease: The VIDEO-KD Randomized Clinical Trial.JAMA Intern Med · 2026 · PMID 42911803
This page is information, not medical advice. Discuss any trial with your doctor.